TY - JOUR
T1 - A Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases
T2 - 2018 Update by the Infectious Diseases Society of America and the American Society for Microbiology
AU - Miller, J. Michael
AU - Binnicker, Matthew J.
AU - Campbell, Sheldon
AU - Carroll, Karen C.
AU - Chapin, Kimberle C.
AU - Gilligan, Peter H.
AU - Gonzalez, Mark D.
AU - Jerris, Robert C.
AU - Kehl, Sue C.
AU - Patel, Robin
AU - Pritt, Bobbi S.
AU - Richter, Sandra S.
AU - Robinson-Dunn, Barbara
AU - Schwartzman, Joseph D.
AU - Snyder, James W.
AU - Telford, Sam
AU - Theel, Elitza S.
AU - Thomson, Richard B.
AU - Weinstein, Melvin P.
AU - Yao, Joseph D.
N1 - Funding Information:
Potential conflicts of interest. For activities outside the submitted work, J. M. M. has received royalties from ASM for his 1999 book A Guide to Specimen Management in Clinical Microbiology, and he serves on the Board of Directors of BioFire Defense. For activities outside the submitted work, M. P. W. has received royalties from UpToDate and payment for consultancies from Rempex, Accelerate Diagnostics, and PDL Biopharma. His institution has received payment for his consultancies with Pfizer and has received grants/pending grants from JMI Labs, BD Diagnostics, Siemens, and bioMérieux that are all outside the submitted work. For activities outside the submitted work, S. S. R. is employed by the Cleveland Clinic and her institution has received grants/grants pending from BD Diagnostics, Nanosphere, bioMérieux, Roche, and ARLG. She has received payment for lectures from the ASM. She has also received payment for travel/accommodations from the College of American Pathologists, the Clinical and Laboratory Standards Institute, and the ASM; all activities are outside of the submitted work. For activities outside the submitted work, P. H. G. has received payment from Mountside Consulting and Diagnostic Microbiology Development Program for consultancies and from SouthEastern Association for Clinical Microbiology, ASM, American Association of Clinical Chemistry, Hospital and Healthcare System Association of Pennsylvania, Eastern Pennsylvania Branch of the American Society for Microbiology, and Illinois Society for Microbiology for lecture honoraria. He has received royalties from ASM. All activities are outside the submitted work. For activities outside the submitted work, R. B. T., has received payment from IDSA for travel to meetings in support of this activity. His institution has received grants/grants pending from Nanosphere, Inc (now Luminex Corp) and Cepheid, both outside the submitted work. For activities outside the submitted work, K. C. serves on the scientific advisory boards of Quidel Biosciences, Inc, and NanoMR, Inc, and her institution has grants/grants pending from Nanosphere, Inc, Biofire, Inc, and AdvanDx. She has received payment for lectures/speakers’ bureaus from the New York City Branch of ASM and royalties from McGraw-Hill; all activities are outside the submitted work. For activities outside the submitted work, S. C. K. received payment from Meridian Bioscience for the development of educational presentations. For activities outside the submitted work, B. R. D. is employed by Beaumont Health System and has received payment for lectures/workshops and travel/accommodations from the ASM. For activities outside the submitted work, J. D. S. is employed by Dartmouth Hitchcock Medical Center and Geisel School of Medicine. For activities outside the submitted work, K. C. C. serves on the Board of ThermoFisher; her institution has received grants/grants pending from BD Diagnostics, Biofire, and Hologic; and she has received payment for lectures/speakers bureaus for BD Diagnostics and Hologic. For activities outside the submitted work, J. W. S. has received payment from IDSA for travel to meetings in support of this activity. He has also received support for lectures/speakers bureaus outside the submitted work from Bellarmine University, Becton Dickinson, and Great Basin Corp. He has also received payment for his consultancies to Jewish Hospital (Louisville, Kentucky) and Floyd Memorial Hospital (New Albany, Indiana) and royalties from Taylor Francis, and his institution has received grants/pending grants from the National Institutes of Health (NIH), all outside the submitted work. For activities outside the submitted work, R. P. is employed by Mayo Clinic and her institution has grants/pending grants from the following: Pfizer, Pradama, Pocared, Astellas, Tornier, and the NIH. She and her institution have patents and receive royalties from Bordetella pertussis/parapertussis polymerase chain reaction and she has received payments for travel/accommodations from ASM, IDSA, International Symposium on Antimicrobial Agents and Resistance (ISAAR), and Asia-Pacific Congress of Clinical Microbiology and Infection (APCCMI) and for her role as Editor of The Journal of Clinical Microbiology. All activities are outside the submitted work. For activities outside the submitted work, B. S. P.’s institution has received payment from the College of American Pathologists for lectures/ speakers’ bureaus and travel/accommodations. For activities outside the submitted work, S. R. T. is a consultant on the diagnosis of tick-borne infections for Immugen, Inc, Immunetics, Inc, Fuller Laboratories, and Meridian Laboratories. All other authors report no potential conflicts of interest. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.
Publisher Copyright:
© The Author(s) 2018.
PY - 2018/8/31
Y1 - 2018/8/31
N2 - The critical nature of the microbiology laboratory in infectious disease diagnosis calls for a close, positive working relationship between the physician/advanced practice provider and the microbiologists who provide enormous value to the healthcare team. This document, developed by experts in laboratory and adult and pediatric clinical medicine, provides information on which tests are valuable and in which contexts, and on tests that add little or no value for diagnostic decisions. This document presents a system-based approach rather than specimen-based approach, and includes bloodstream and cardiovascular system infections, central nervous system infections, ocular infections, soft tissue infections of the head and neck, upper and lower respiratory infections, infections of the gastrointestinal tract, intra-abdominal infections, bone and joint infections, urinary tract infections, genital infections, and other skin and soft tissue infections; or into etiologic agent groups, including arthropod-borne infections, viral syndromes, and blood and tissue parasite infections. Each section contains introductory concepts, a summary of key points, and detailed tables that list suspected agents; the most reliable tests to order; the samples (and volumes) to collect in order of preference; specimen transport devices, procedures, times, and temperatures; and detailed notes on specific issues regarding the test methods, such as when tests are likely to require a specialized laboratory or have prolonged turnaround times. In addition, the pediatric needs of specimen management are also emphasized. There is intentional redundancy among the tables and sections, as many agents and assay choices overlap. The document is intended to serve as a guidance for physicians in choosing tests that will aid them to quickly and accurately diagnose infectious diseases in their patients.
AB - The critical nature of the microbiology laboratory in infectious disease diagnosis calls for a close, positive working relationship between the physician/advanced practice provider and the microbiologists who provide enormous value to the healthcare team. This document, developed by experts in laboratory and adult and pediatric clinical medicine, provides information on which tests are valuable and in which contexts, and on tests that add little or no value for diagnostic decisions. This document presents a system-based approach rather than specimen-based approach, and includes bloodstream and cardiovascular system infections, central nervous system infections, ocular infections, soft tissue infections of the head and neck, upper and lower respiratory infections, infections of the gastrointestinal tract, intra-abdominal infections, bone and joint infections, urinary tract infections, genital infections, and other skin and soft tissue infections; or into etiologic agent groups, including arthropod-borne infections, viral syndromes, and blood and tissue parasite infections. Each section contains introductory concepts, a summary of key points, and detailed tables that list suspected agents; the most reliable tests to order; the samples (and volumes) to collect in order of preference; specimen transport devices, procedures, times, and temperatures; and detailed notes on specific issues regarding the test methods, such as when tests are likely to require a specialized laboratory or have prolonged turnaround times. In addition, the pediatric needs of specimen management are also emphasized. There is intentional redundancy among the tables and sections, as many agents and assay choices overlap. The document is intended to serve as a guidance for physicians in choosing tests that will aid them to quickly and accurately diagnose infectious diseases in their patients.
KW - clinical correlation
KW - clinical relevance
KW - microbiology specimens.
KW - specimen collection
KW - specimen management
UR - http://www.scopus.com/inward/record.url?scp=85054993925&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85054993925&partnerID=8YFLogxK
U2 - 10.1093/cid/ciy584
DO - 10.1093/cid/ciy584
M3 - Article
C2 - 30169655
AN - SCOPUS:85054993925
SN - 1058-4838
VL - 67
SP - 813
EP - 816
JO - Clinical Infectious Diseases
JF - Clinical Infectious Diseases
IS - 6
ER -